Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Pharma

It's time to get comfortable with being uncomfortable.

Partner, Health & Life Sciences, Oliver Wyman

How to ensure medications work as intended for different patient populations.

Chief Executive Officer, Aetion
Partner, Health & Life Sciences, Oliver Wyman

A series of perspectives on the state of data in healthcare.

Some of our 2018 predictions on consolidation, pharma, and investment came true, while others were less predictable.

Principal, Oliver Wyman

Once J.P. Morgan Healthcare Week comes to a close, companies will need to show as much as they tell.

Chief Strategist, Health Practice, Edelman

Insights in your inbox

Subscribe

The key to measurement-based digital mental healthcare intervention and assessment? A patient's smartphone.

Some of our 2017 healthcare predictions on value-based care, consumers, mergers, startups, and pharma came true, while others were less predictable.

Principal, Oliver Wyman

What's around the bend for healthcare venture capital in 2018? We talk Amazon, good and bad M&A, and hitting the investment peak.

Senior Managing Director, GE Ventures

Trendspotting in unpredictable times. This infographic highlights five predictions for 2017.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Head of Health & Life Sciences, North America, Oliver Wyman

Even amidst the uncertainty of repeal and replace, we see some meaningful trends taking shape. Read our predictions for 2017.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Head of Health & Life Sciences, North America, Oliver Wyman

Insights in your inbox

Subscribe